Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...

The drugmaker has become a clear winner with its weight-loss drugs. Now, with a pill under development, the company should ...

UBS has reiterated its Buy rating and $1,050 price target on LLY stock, highlighting the company’s growing dominance in the ...

Shares in Eli Lilly rose sharply in pre-market trading today after it reported phase 3 results for oral diabetes and weight-loss drug orforglipron.

Weight loss pills have been around for decades, but many were deemed unsafe by the FDA. Now, as better-regulated drugs hit the market, here’s what to know about their safety and side effects.

Shares in Eli Lilly have weakened after pharmacy benefit manager CVS Health said it would no longer cover its weight-loss therapy Zepbound.

Beans are rich in protein, fiber and other health-boosting nutrients. A dietitian shares the top high-protein beans to add to your diet.

View the most recent data and latest information on option chains for Eli Lilly and Company Common Stock (LLY) at Nasdaq.com.

Bull or Bear, Seeking Alpha is there Markets change, but our community always has the latest in-depth analysis and powerful stock ratings. New! Get unlimited access to breaking stock news—for free.

Bull or Bear, Seeking Alpha is there Markets change, but our community always has the latest in-depth analysis and powerful stock ratings. New! Get unlimited access to breaking stock news—for free.